Article Information
History
- July 25, 2022.
Article Versions
- Version 1 (October 23, 2020 - 05:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michal Marek Hoppe, PhD1,
- Patrick Jaynes, PhD1,
- Fan Shuangyi, MD2,
- Yanfen Peng, MSc1,
- Phuong Mai Hoang, PhD1,
- Liu Xin, MA3,
- Sanjay De Mel, MBBS3,4,
- Limei Poon, MBBS3,4,
- Esther Chan, MBBS3,4,
- Joanne Lee, MBBS3,4,
- Choon Kiat Ong, PhD5,
- Tiffany Tang, MBBS6,
- Soon Thye Lim, MBBS6,
- Chandramouli Nagarajan, MBBS7,
- Nicholas Francis Grigoropoulos, MBBS, PhD7,
- Soo-Yong Tan, MBBS DPhil2,4,
- Susan Swee-Shan Hue, MBBS2,4,
- Sheng-Tsung Chang, MD8,
- Shih-Sung Chuang, MD8,
- Shaoying Li, MD9,
- Joseph D. Khoury, MD9,
- Hyungwon Choi, PhD10,
- Carl Harris III, PhD11,
- Alessia Bottos, PhD11,
- Laura J. Gay, PhD12,
- Hendrik F. P. Runge, BSc12,
- Ilias Moutsopoulos, BSc12,
- Irina Mohorianu, PhD12,
- Daniel J. Hodson, MBBChir PhD12,
- Pedro Farinha, MD13,
- Anja Mottok, MD13,
- David W. Scott, MBChB PhD13,
- Gayatri Kumar, PhD14,
- Kasthuri Kannan, PhD14,
- Wee-Joo Chng, MBChB PhD1,4,10,
- Yen Lin Chee, MBChB PhD3,4,
- Siok-Bian Ng, MBBS1,2,4,
- Claudio Tripodo, MD PhD15,* and
- Anand D. Jeyasekharan, MBBS PhD1,3,4,10,*
- 1Cancer Science Institute of Singapore, National University of Singapore, Singapore
- 2Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- 3Department of Haematology-Oncology, National University Health System, Singapore
- 4NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore
- 5Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore
- 6Division of Medical Oncology, National Cancer Centre Singapore, Singapore
- 7Department of Haematology, Singapore General Hospital, Singapore
- 8Department of Pathology, Chi-Mei Medical Center, Tainan City, Taiwan
- 9Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
- 10Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- 11F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 12Wellcome MRC Cambridge Stem Cell Institute, Cambridge, UK
- 13BC Cancer Research Centre, Vancouver, Canada
- 14Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
- 15Tumor Immunology Unit, University of Palermo, Palermo, Italy
- ↵*To whom correspondence is to be addressed Dr Anand D. Jeyasekharan; Cancer Science Institute of Singapore, Centre for Translational Medicine (MD6) #13-01G, 14 Medical Drive, Singapore 117599; csiadj{at}nus.edu.sg; Prof. Claudio Tripodo; University of Palermo School of Medicine, Istituto di Patologia Generale Corso Tukory 211, 90134, Palermo, Italy; claudio.tripodo{at}unipa.it